These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 26912631)

  • 1. Natural Single-Nucleotide Variations in the HIV-1 Genomic SA1prox Region Can Alter Viral Replication Ability by Regulating Vif Expression Levels.
    Nomaguchi M; Doi N; Sakai Y; Ode H; Iwatani Y; Ueno T; Matsumoto Y; Miyazaki Y; Masuda T; Adachi A
    J Virol; 2016 May; 90(9):4563-4578. PubMed ID: 26912631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Expression Level of HIV-1 Vif Is Optimized by Nucleotide Changes in the Genomic SA1D2prox Region during the Viral Adaptation Process.
    Koma T; Doi N; Takemoto M; Watanabe K; Yamamoto H; Nakashima S; Adachi A; Nomaguchi M
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Vif mRNA splicing by human immunodeficiency virus type 1 requires 5' splice site D2 and an exonic splicing enhancer to counteract cellular restriction factor APOBEC3G.
    Mandal D; Exline CM; Feng Z; Stoltzfus CM
    J Virol; 2009 Jun; 83(12):6067-78. PubMed ID: 19357165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Competing HIV-1 Splice Donor Sites Uncovers a Tight Cluster of Splicing Regulatory Elements within Exon 2/2b.
    Brillen AL; Walotka L; Hillebrand F; Müller L; Widera M; Theiss S; Schaal H
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28446664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative and positive mRNA splicing elements act competitively to regulate human immunodeficiency virus type 1 vif gene expression.
    Exline CM; Feng Z; Stoltzfus CM
    J Virol; 2008 Apr; 82(8):3921-31. PubMed ID: 18272582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-APOBEC3G activity of HIV-1 Vif protein is attenuated in elite controllers.
    Kikuchi T; Iwabu Y; Tada T; Kawana-Tachikawa A; Koga M; Hosoya N; Nomura S; Brumme ZL; Jessen H; Pereyra F; Trocha A; Walker BD; Iwamoto A; Tokunaga K; Miura T
    J Virol; 2015 May; 89(9):4992-5001. PubMed ID: 25717111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An intronic G run within HIV-1 intron 2 is critical for splicing regulation of vif mRNA.
    Widera M; Erkelenz S; Hillebrand F; Krikoni A; Widera D; Kaisers W; Deenen R; Gombert M; Dellen R; Pfeiffer T; Kaltschmidt B; Münk C; Bosch V; Köhrer K; Schaal H
    J Virol; 2013 Mar; 87(5):2707-20. PubMed ID: 23255806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural single-nucleotide polymorphisms in the 3' region of the HIV-1 pol gene modulate viral replication ability.
    Nomaguchi M; Miyake A; Doi N; Fujiwara S; Miyazaki Y; Tsunetsugu-Yokota Y; Yokoyama M; Sato H; Masuda T; Adachi A
    J Virol; 2014 Apr; 88(8):4145-60. PubMed ID: 24478432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and functional characterization of HIV-1 Vif on APOBEC3G degradation: First report of emergence of B/C recombinants from North India.
    Ronsard L; Raja R; Panwar V; Saini S; Mohankumar K; Sridharan S; Padmapriya R; Chaudhuri S; Ramachandran VG; Banerjea AC
    Sci Rep; 2015 Oct; 5():15438. PubMed ID: 26494109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A functional conserved intronic G run in HIV-1 intron 3 is critical to counteract APOBEC3G-mediated host restriction.
    Widera M; Hillebrand F; Erkelenz S; Vasudevan AA; Münk C; Schaal H
    Retrovirology; 2014 Aug; 11():72. PubMed ID: 25169827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A suboptimal 5' splice site downstream of HIV-1 splice site A1 is required for unspliced viral mRNA accumulation and efficient virus replication.
    Madsen JM; Stoltzfus CM
    Retrovirology; 2006 Feb; 3():10. PubMed ID: 16457729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.
    Xu H; Svarovskaia ES; Barr R; Zhang Y; Khan MA; Strebel K; Pathak VK
    Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5652-7. PubMed ID: 15054139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A naturally occurring Vif mutant (I107T) attenuates anti-APOBEC3G activity and HIV-1 replication.
    Peng J; Ao Z; Matthews C; Wang X; Ramdahin S; Chen X; Li J; Chen L; He J; Ball B; Fowke K; Plummer F; Embree J; Yao X
    J Mol Biol; 2013 Aug; 425(16):2840-52. PubMed ID: 23707381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication.
    Krisko JF; Begum N; Baker CE; Foster JL; Garcia JV
    J Virol; 2016 May; 90(9):4681-4695. PubMed ID: 26912618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 subtype variability in Vif derived from molecular clones affects APOBEC3G-mediated host restriction.
    Lisovsky I; Schader SM; Sloan RD; Oliveira M; Coutsinos D; Bernard NF; Wainberg MA
    Intervirology; 2013; 56(4):258-64. PubMed ID: 23689841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An analog of camptothecin inactive against Topoisomerase I is broadly neutralizing of HIV-1 through inhibition of Vif-dependent APOBEC3G degradation.
    Bennett RP; Stewart RA; Hogan PA; Ptak RG; Mankowski MK; Hartman TL; Buckheit RW; Snyder BA; Salter JD; Morales GA; Smith HC
    Antiviral Res; 2016 Dec; 136():51-59. PubMed ID: 27825797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ring finger protein ZIN interacts with human immunodeficiency virus type 1 Vif.
    Feng F; Davis A; Lake JA; Carr J; Xia W; Burrell C; Li P
    J Virol; 2004 Oct; 78(19):10574-81. PubMed ID: 15367624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pokeweed antiviral protein restores levels of cellular APOBEC3G during HIV-1 infection by depurinating Vif mRNA.
    Krivdova G; Hudak KA
    Antiviral Res; 2015 Oct; 122():51-4. PubMed ID: 26275799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conserved Interaction of Lentiviral Vif Molecules with HIV-1 Gag and Differential Effects of Species-Specific Vif on Virus Production.
    Zheng W; Ling L; Li Z; Wang H; Rui Y; Gao W; Wang S; Su X; Wei W; Yu XF
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28122978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Camelized rabbit-derived VH single-domain intrabodies against Vif strongly neutralize HIV-1 infectivity.
    Aires da Silva F; Santa-Marta M; Freitas-Vieira A; Mascarenhas P; Barahona I; Moniz-Pereira J; Gabuzda D; Goncalves J
    J Mol Biol; 2004 Jul; 340(3):525-42. PubMed ID: 15210352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.